Department of Medicine A, Assuta University Hospital, Ben-Gurion University of the Negev Faculty of Health Sciences, Ashdod, Israel.
Rheumatic Diseases Unit, Ha'Emek MC, 18101, Afula, Israel.
Arthritis Res Ther. 2020 Aug 17;22(1):190. doi: 10.1186/s13075-020-02278-w.
To describe actual cardiovascular events over a decade in patients with diffuse idiopathic skeletal hyperostosis (DISH), without previously known CV diseases.
The medical records of patients with DISH and controls, beginning in 2006 (without known CV disease), were reviewed. Demographic, constitutional, and laboratory data were collected. Comparison of CV events following 2006 was performed according to the outcome definitions set by the Framingham score 2: coronary event demonstrated by a coronary imaging modality, acute myocardial infarction (MI), coronary death, congestive heart failure with a reduced ejection fraction, and angina pectoris.
Data were available for 45 patients with DISH and 47 controls without DISH from the original cohort (91.8% and 97.9% respectively). By the Framingham score, 28.6% (± 20.33) of the DISH patients were expected to be affected with CVD at 10 years of follow-up. We observed that nearly 39% of them developed CVD during that period (95% CI 23.8-53.5%). The incidence of MI over the 10-year period was significantly higher in the DISH group (P = 0.005). The DISH group had higher morbidity with a higher composite outcome of 38.8% vs 25.5% in the control cohort, and the number of non-elective hospital admissions per patient, despite neither reaching statistical significance.
Our study showed that the Framingham score underestimates the real risk for developing CVD in patients with DISH, specifically the risk for MI. We propose more scrutiny is warranted in evaluating CV risk in these patients, more demanding treatment target goals should be established, and earlier and more aggressive medical interventions should be undertaken, particularly primary prevention. Larger prospective studies are needed to corroborate these findings.
描述患有弥漫性特发性骨肥厚症(DISH)且无先前已知心血管疾病的患者在十年内的实际心血管事件。
回顾了 2006 年(无已知心血管疾病)开始患有 DISH 和对照组患者的病历。收集了人口统计学、体质和实验室数据。根据Framingham 评分 2 设定的结果定义比较 2006 年后的 CV 事件:通过冠状动脉成像方式显示的冠状动脉事件、急性心肌梗死(MI)、冠状动脉死亡、射血分数降低的充血性心力衰竭和心绞痛。
原始队列中,有 45 名 DISH 患者和 47 名无 DISH 的对照组患者的数据可用(分别为 91.8%和 97.9%)。根据 Framingham 评分,预计 DISH 患者中有 28.6%(±20.33)在 10 年随访期间会出现 CVD。我们发现,在此期间,近 39%的患者发生了 CVD(95%CI 23.8-53.5%)。在 10 年期间,DISH 组的 MI 发病率明显更高(P=0.005)。尽管没有达到统计学意义,但 DISH 组的复合结局发病率更高,为 38.8%,而对照组为 25.5%,每位患者的非择期住院人数也更高。
我们的研究表明,Framingham 评分低估了 DISH 患者发生 CVD 的真实风险,特别是 MI 的风险。我们建议在评估这些患者的 CV 风险时需要更仔细的审查,应制定更严格的治疗目标,应尽早采取更积极的医疗干预措施,特别是进行初级预防。需要更大规模的前瞻性研究来证实这些发现。